Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

New tools for coronary risk assessment: what are their advantages and limitations?

Pearson TA.

Circulation. 2002 Feb 19;105(7):886-92. Review.

4.

Noninvasive detection of coronary artery disease -- challenges for prevention of disease and clinical events.

da Luz PL, Bertini PJ, Favarato D.

Clinics (Sao Paulo). 2005 Oct;60(5):415-28. Epub 2005 Oct 24. Review.

6.

From vulnerable plaque to vulnerable patient--Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report.

Naghavi M, Falk E, Hecht HS, Jamieson MJ, Kaul S, Berman D, Fayad Z, Budoff MJ, Rumberger J, Naqvi TZ, Shaw LJ, Faergeman O, Cohn J, Bahr R, Koenig W, Demirovic J, Arking D, Herrera VL, Badimon J, Goldstein JA, Rudy Y, Airaksinen J, Schwartz RS, Riley WA, Mendes RA, Douglas P, Shah PK; SHAPE Task Force..

Am J Cardiol. 2006 Jul 17;98(2A):2H-15H. Epub 2006 Jun 12. Review.

PMID:
16843744
8.

[Electron-beam computed tomography for identification of high-risk persons in primary prevention of coronary heart disease in the United States and its implication for Japan].

Sekikawa A, Okamura T, Kadowaki T, Mitsunami K, Murata K, Kashiwagi A, Nakamura Y, Kanda H, Edmundowicz D, Sutton-Tyrrell K, Curb JD, Kuller LH, Ueshima H.

Nihon Koshu Eisei Zasshi. 2003 Mar;50(3):183-93. Review. Japanese.

PMID:
12704831
9.

[Cardiovascular risk factors and prevention in women: similarities and differences].

Sclavo M.

Ital Heart J Suppl. 2001 Feb;2(2):125-41. Review. Italian.

PMID:
11255880
10.

Prevention of coronary heart disease. Part I. Primary prevention.

Liebson PR, Amsterdam EA.

Dis Mon. 1999 Dec;45(12):497-571. Review.

PMID:
10711300
11.

Noninvasive surrogate markers of atherosclerosis.

Feinstein SB, Voci P, Pizzuto F.

Am J Cardiol. 2002 Mar 7;89(5A):31C-43C; discussion 43C-44C. Review.

PMID:
11900717
12.

[Statins in primary prevention of coronary heart disease].

Paulweber B.

Wien Med Wochenschr. 1999;149(5-6):129-38. Review. German.

PMID:
10408004
13.

Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.

Evans M, Roberts A, Davies S, Rees A.

Drugs. 2004;64(11):1181-96. Review.

PMID:
15161326
14.

High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy.

Koenig W.

Int J Cardiol. 2013 Oct 15;168(6):5126-34. doi: 10.1016/j.ijcard.2013.07.113. Epub 2013 Aug 24. Review.

PMID:
23978367
15.

Non-invasive measurement of coronary heart disease using electron beam computed tomography.

Valabhji J, Elkeles RS.

Curr Opin Lipidol. 2002 Aug;13(4):409-14. Review.

PMID:
12151856
16.

Coronary artery disease: diagnostic and prognostic models for reducing patient risk.

Miller DD, Shaw LJ.

J Cardiovasc Nurs. 2006 Nov-Dec;21(6 Suppl 1):S2-16; quiz S17-9. Review.

PMID:
17293746
17.

A new method for CHD prediction and prevention based on regional risk scores and randomized clinical trials; PRECARD and the Copenhagen Risk Score.

Thomsen TF, Davidsen M, Ibsen H, Jørgensen T, Jensen G, Borch-Johnsen K.

J Cardiovasc Risk. 2001 Oct;8(5):291-7. Review. Erratum in: J Cardiovasc Risk 2001 Dec;8(6):391.

PMID:
11702035
18.

Cholesterol and atherosclerosis: a contemporary perspective.

Kashyap ML.

Ann Acad Med Singapore. 1997 Jul;26(4):517-23. Review.

PMID:
9395824
19.
20.

Cholesterol, lipoproteins, and coronary heart disease in women.

Bush TL, Fried LP, Barrett-Connor E.

Clin Chem. 1988;34(8B):B60-70. Review.

PMID:
3042201

Supplemental Content

Support Center